ICER-话题@MedSci - 梅斯（MedSci）

#ICER#

13篇内容 | 1024人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997056, encodeId=b924199e056cb, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=ICER评估Roctavian和EtranaDez基因疗法治疗A型和B型血友病, objectType=article, longId=726366, objectId=421ee263669d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=421ee263669d, replyNumber=0, likeNumber=93, createdTime=2023-04-04, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=421ee263669d, moduleTitle=ICER评估Roctavian和EtranaDez基因疗法治疗A型和B型血友病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=421ee263669d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997053, encodeId=3274199e05389, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=勃林格殷格翰通过与Dicerna的研究合作取得第二个肝病靶点的期权, objectType=article, longId=157792, objectId=26c515e792bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26c515e792bf, replyNumber=0, likeNumber=98, createdTime=2019-05-06, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26c515e792bf, moduleTitle=勃林格殷格翰通过与Dicerna的研究合作取得第二个肝病靶点的期权, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=26c515e792bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997054, encodeId=0f2a199e054a0, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=临床和经济评论研究所（ICER）：PCSK9抑制剂Alirocumab治疗高胆固醇症的证据更新, objectType=article, longId=160533, objectId=43881605336e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43881605336e, replyNumber=0, likeNumber=105, createdTime=2020-01-01, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43881605336e, moduleTitle=临床和经济评论研究所（ICER）：PCSK9抑制剂Alirocumab治疗高胆固醇症的证据更新, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=43881605336e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997052, encodeId=f6ea199e052f8, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=Circulation：巨噬细胞的Dicer通过调节线粒体氧化代谢抵制动脉粥样硬化, objectType=article, longId=152724, objectId=1a96152e24f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a96152e24f5, replyNumber=0, likeNumber=78, createdTime=2018-12-26, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a96152e24f5, moduleTitle=Circulation：巨噬细胞的Dicer通过调节线粒体氧化代谢抵制动脉粥样硬化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1a96152e24f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997055, encodeId=7b16199e055eb, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=Mol Med Rep：Dicer的缺失通过抑制Wnt信号传导阻断成骨分化, objectType=article, longId=161649, objectId=dbf916164915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbf916164915, replyNumber=0, likeNumber=65, createdTime=2019-04-30, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbf916164915, moduleTitle=Mol Med Rep：Dicer的缺失通过抑制Wnt信号传导阻断成骨分化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dbf916164915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997051, encodeId=6821199e051cb, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=药物经济学中增量成本效果比（ICER）与净收益（Net Benefit）, objectType=article, longId=151281, objectId=7a49151281b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a49151281b8, replyNumber=0, likeNumber=73, createdTime=2019-09-14, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a49151281b8, moduleTitle=药物经济学中增量成本效果比（ICER）与净收益（Net Benefit）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7a49151281b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997049, encodeId=5c27199e0497d, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=ICER最终报告：Elagolix对子宫内膜异位症的长期安全性和有效性, objectType=article, longId=145943, objectId=58ce14594383, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58ce14594383, replyNumber=0, likeNumber=69, createdTime=2018-09-19, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58ce14594383, moduleTitle=ICER最终报告：Elagolix对子宫内膜异位症的长期安全性和有效性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=58ce14594383)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997050, encodeId=ff92199e050d4, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=ICER：Guselkumab和Risankizumab靶向治疗斑块状银屑病具有更高的临床益处, objectType=article, longId=145944, objectId=6e0014594413, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e0014594413, replyNumber=0, likeNumber=69, createdTime=2019-01-02, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e0014594413, moduleTitle=ICER：Guselkumab和Risankizumab靶向治疗斑块状银屑病具有更高的临床益处, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6e0014594413)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997045, encodeId=0e5c199e045ac, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=Cancer Res：aP2-Cre介导等位基因Dicer1缺失导致血管肉瘤发生, objectType=article, longId=121470, objectId=54011214e06e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54011214e06e, replyNumber=0, likeNumber=70, createdTime=2018-02-17, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54011214e06e, moduleTitle=Cancer Res：aP2-Cre介导等位基因Dicer1缺失导致血管肉瘤发生, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=54011214e06e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997047, encodeId=add5199e047e9, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=Cell丨清华王宏伟组揭示人源Dicer蛋白的工作机制——王艳丽、麻锦彪点评, objectType=article, longId=136666, objectId=6fb71366660f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fb71366660f, replyNumber=0, likeNumber=79, createdTime=2019-02-28, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fb71366660f, moduleTitle=Cell丨清华王宏伟组揭示人源Dicer蛋白的工作机制——王艳丽、麻锦彪点评, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6fb71366660f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997048, encodeId=d881199e048a2, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=Hepatology：MicroRNA-21和Dicer对于肝星状细胞的激活和肝纤维化的发展不是不可或缺的, objectType=article, longId=140490, objectId=1d4c14049047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d4c14049047, replyNumber=0, likeNumber=69, createdTime=2018-06-10, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d4c14049047, moduleTitle=Hepatology：MicroRNA-21和Dicer对于肝星状细胞的激活和肝纤维化的发展不是不可或缺的, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1d4c14049047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997046, encodeId=b5ad199e046ac, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=JCEM:DICER1突变在儿童发生的甲状腺乳头状癌中频率如何？, objectType=article, longId=130312, objectId=18811303124a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18811303124a, replyNumber=0, likeNumber=71, createdTime=2018-11-08, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18811303124a, moduleTitle=JCEM:DICER1突变在儿童发生的甲状腺乳头状癌中频率如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=18811303124a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997044, encodeId=74b9199e04436, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, objectTitle=勃林格殷格翰与Dicerna制药公司就非酒精性脂肪性肝炎等疾病的治疗开展合作, objectType=article, longId=120150, objectId=a86d120150ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a86d120150ef, replyNumber=0, likeNumber=79, createdTime=2017-12-15, rootId=0, userName=chenwq08, userId=365d170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a86d120150ef, moduleTitle=勃林格殷格翰与Dicerna制药公司就非酒精性脂肪性肝炎等疾病的治疗开展合作, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a86d120150ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ICER

2020-05-29

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

ICER评估Roctavian和EtranaDez基因疗法治疗A型和B型血友病

2023-04-04

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

勃林格殷格翰通过与Dicerna的研究合作取得第二个肝病靶点的期权

2019-05-06

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

临床和经济评论研究所（ICER）：PCSK9抑制剂Alirocumab治疗高胆固醇症的证据更新

2020-01-01

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

Circulation：巨噬细胞的Dicer通过调节线粒体氧化代谢抵制动脉粥样硬化

2018-12-26

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

Mol Med Rep：Dicer的缺失通过抑制Wnt信号传导阻断成骨分化

2019-04-30

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

药物经济学中增量成本效果比（ICER）与净收益（Net Benefit）

2019-09-14

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

ICER最终报告：Elagolix对子宫内膜异位症的长期安全性和有效性

2018-09-19

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

ICER：Guselkumab和Risankizumab靶向治疗斑块状银屑病具有更高的临床益处

2019-01-02

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

Cancer Res：aP2-Cre介导等位基因Dicer1缺失导致血管肉瘤发生

2018-02-17

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

Cell丨清华王宏伟组揭示人源Dicer蛋白的工作机制——王艳丽、麻锦彪点评

2019-02-28

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

Hepatology：MicroRNA-21和Dicer对于肝星状细胞的激活和肝纤维化的发展不是不可或缺的

2018-06-10

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

JCEM:DICER1突变在儿童发生的甲状腺乳头状癌中频率如何？

2018-11-08

chenwq08 (审核中...)

前往app查看评论内容

#ICER#

勃林格殷格翰与Dicerna制药公司就非酒精性脂肪性肝炎等疾病的治疗开展合作

2017-12-15

科室
- - 订阅+
  - 更多科室
工具
服务